Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million Post author:Sam Post published:February 28, 2018 Post category:BioPharma Finch Therapeutics closed on an oversubscribed Series B financing worth $36 million. Source: BioSpace You Might Also Like <b>Medical Device Innovation Consortium</b> Announces <b>Rachael L. Fleurence</b>, Ph.D. Appointed As Executive Director Of The <b>National Evaluation System For Health Technology Coordinating Center</b> (NESTcc) April 11, 2017 3 Biotech Stocks Able to Weather an Unstable Administration February 9, 2017 3 Biotechs That Could be Sweet M&A Targets for Big Pharma July 5, 2017
<b>Medical Device Innovation Consortium</b> Announces <b>Rachael L. Fleurence</b>, Ph.D. Appointed As Executive Director Of The <b>National Evaluation System For Health Technology Coordinating Center</b> (NESTcc) April 11, 2017
